Annual long term liabilities:
$2.42B-$148.46M(-5.79%)Summary
- As of today (September 18, 2025), AMRX annual total long term liabilities is $2.42 billion, with the most recent change of -$148.46 million (-5.79%) on December 31, 2024.
- During the last 3 years, AMRX annual long term liabilities has fallen by -$462.33 million (-16.06%).
- AMRX annual long term liabilities is now -18.71% below its all-time high of $2.97 billion, reached on December 31, 2020.
Performance
AMRX Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$2.36B+$13.57M(+0.58%)Summary
- As of today (September 18, 2025), AMRX quarterly total long term liabilities is $2.36 billion, with the most recent change of +$13.57 million (+0.58%) on June 30, 2025.
- Over the past year, AMRX quarterly long term liabilities has dropped by -$37.25 million (-1.55%).
- AMRX quarterly long term liabilities is now -21.73% below its all-time high of $3.02 billion, reached on June 30, 2020.
Performance
AMRX quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
AMRX Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.8% | -1.6% |
| 3 y3 years | -16.1% | -17.3% |
| 5 y5 years | +6004.2% | -21.7% |
AMRX Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -16.1% | at low | -17.3% | +0.6% |
| 5 y | 5-year | -18.7% | +6004.2% | -21.7% | +0.6% |
| alltime | all time | -18.7% | >+9999.0% | -21.7% | >+9999.0% |
AMRX Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $2.36B(+0.6%) |
| Mar 2025 | - | $2.35B(-2.8%) |
| Dec 2024 | $2.42B(-5.8%) | $2.42B(+0.7%) |
| Sep 2024 | - | $2.40B(-0.0%) |
| Jun 2024 | - | $2.40B(-9.1%) |
| Mar 2024 | - | $2.64B(+2.9%) |
| Dec 2023 | $2.56B(-9.6%) | $2.56B(-6.2%) |
| Sep 2023 | - | $2.74B(-0.2%) |
| Jun 2023 | - | $2.74B(-0.7%) |
| Mar 2023 | - | $2.76B(-2.7%) |
| Dec 2022 | $2.84B(-1.4%) | $2.84B(-0.1%) |
| Sep 2022 | - | $2.84B(-0.6%) |
| Jun 2022 | - | $2.86B(-0.2%) |
| Mar 2022 | - | $2.86B(-0.5%) |
| Dec 2021 | $2.88B(-3.2%) | $2.88B(-1.0%) |
| Sep 2021 | - | $2.91B(-1.3%) |
| Jun 2021 | - | $2.95B(+0.1%) |
| Mar 2021 | - | $2.94B(-1.0%) |
| Dec 2020 | $2.97B(+7409.3%) | $2.97B(-1.2%) |
| Sep 2020 | - | $3.01B(-0.3%) |
| Jun 2020 | - | $3.02B(+0.3%) |
| Mar 2020 | - | $3.01B(+7503.6%) |
| Dec 2019 | $39.58M(-83.0%) | $39.58M(-98.6%) |
| Sep 2019 | - | $2.77B(-6.5%) |
| Jun 2019 | - | $2.97B(-0.6%) |
| Mar 2019 | - | $2.99B(+1182.1%) |
| Dec 2018 | $232.84M(+819.3%) | $232.84M(-3.9%) |
| Sep 2018 | - | $242.35M(-0.3%) |
| Jun 2018 | - | $242.98M(>+9900.0%) |
| Mar 2018 | - | $0.00(-100.0%) |
| Dec 2017 | $25.33M(-97.1%) | $25.33M(-97.1%) |
| Dec 2016 | $877.72M(+707.3%) | - |
| Dec 2016 | - | $877.72M(-0.4%) |
| Sep 2016 | - | $881.26M(+1069.8%) |
| Jun 2016 | - | $75.33M(-10.8%) |
| Mar 2016 | - | $84.45M(-22.3%) |
| Dec 2015 | $108.72M(+222.5%) | $108.72M(-46.0%) |
| Sep 2015 | - | $201.31M(-14.9%) |
| Jun 2015 | - | $236.66M(-3.3%) |
| Mar 2015 | - | $244.69M(+625.8%) |
| Dec 2014 | $33.71M(-5.0%) | $33.71M(+0.6%) |
| Sep 2014 | - | $33.52M(+0.1%) |
| Jun 2014 | - | $33.47M(-1.0%) |
| Mar 2014 | - | $33.81M(-4.7%) |
| Dec 2013 | $35.49M(+28.7%) | $35.49M(+14.3%) |
| Sep 2013 | - | $31.04M(+2.7%) |
| Jun 2013 | - | $30.22M(-5.9%) |
| Mar 2013 | - | $32.11M(+16.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $27.57M(-18.9%) | $27.57M(-24.1%) |
| Sep 2012 | - | $36.33M(+0.6%) |
| Jun 2012 | - | $36.11M(+0.4%) |
| Mar 2012 | - | $35.96M(+5.8%) |
| Dec 2011 | $33.99M(-48.3%) | $33.99M(-9.9%) |
| Sep 2011 | - | $37.71M(-15.5%) |
| Jun 2011 | - | $44.64M(-9.7%) |
| Mar 2011 | - | $49.42M(-24.8%) |
| Dec 2010 | $65.76M(-76.3%) | $65.76M(+30.4%) |
| Sep 2010 | - | $50.42M(-44.5%) |
| Jun 2010 | - | $90.88M(-60.8%) |
| Mar 2010 | - | $231.94M(-16.3%) |
| Dec 2009 | $277.15M(+48.4%) | $277.15M(+15.4%) |
| Sep 2009 | - | $240.18M(-2.4%) |
| Jun 2009 | - | $246.20M(-0.7%) |
| Mar 2009 | - | $247.91M(+28.6%) |
| Dec 2008 | $186.77M(+21.7%) | $192.76M(-11.0%) |
| Sep 2008 | - | $216.54M(+22.9%) |
| Jun 2008 | - | $176.14M(+1.2%) |
| Dec 2007 | $153.49M(-38.4%) | $174.00M(-30.1%) |
| Dec 2006 | $249.11M(+154.1%) | $249.11M(+132.7%) |
| Dec 2005 | $98.03M(+304.5%) | - |
| Sep 2004 | - | $107.03M(-0.1%) |
| Jun 2004 | - | $107.18M(+841.5%) |
| Mar 2004 | - | $11.38M(-53.0%) |
| Dec 2003 | $24.23M(-39.6%) | $24.23M(-11.8%) |
| Sep 2003 | - | $27.48M(-34.0%) |
| Jun 2003 | - | $41.63M(+0.2%) |
| Mar 2003 | - | $41.56M(+3.7%) |
| Dec 2002 | $40.09M(+34.3%) | $40.09M(-8.2%) |
| Sep 2002 | - | $43.68M(+7.3%) |
| Jun 2002 | - | $40.69M(+7.9%) |
| Mar 2002 | - | $37.71M(+26.3%) |
| Dec 2001 | $29.86M(+1611.2%) | $29.86M(+12.6%) |
| Sep 2001 | - | $26.53M(+1.5%) |
| Jun 2001 | - | $26.13M(+1428.0%) |
| Mar 2001 | - | $1.71M(-2.0%) |
| Dec 2000 | $1.75M(-13.2%) | $1.75M(-7.3%) |
| Sep 2000 | - | $1.88M(-2.2%) |
| Jun 2000 | - | $1.93M(-2.2%) |
| Mar 2000 | - | $1.97M(-2.1%) |
| Dec 1999 | $2.01M(+2.2%) | $2.01M(+9.5%) |
| Sep 1999 | - | $1.84M(-2.1%) |
| Jun 1999 | - | $1.88M(-2.2%) |
| Mar 1999 | - | $1.92M(-2.5%) |
| Dec 1998 | $1.97M | $1.97M(-2.0%) |
| Sep 1998 | - | $2.01M(-2.1%) |
| Jun 1998 | - | $2.05M(-1.9%) |
| Mar 1998 | - | $2.09M |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual total long term liabilities?
- What is the all time high annual long term liabilities for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual long term liabilities year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly long term liabilities year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual total long term liabilities?
The current annual long term liabilities of AMRX is $2.42B
What is the all time high annual long term liabilities for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual total long term liabilities is $2.97B
What is Amneal Pharmaceuticals, Inc. annual long term liabilities year-on-year change?
Over the past year, AMRX annual total long term liabilities has changed by -$148.46M (-5.79%)
What is Amneal Pharmaceuticals, Inc. quarterly total long term liabilities?
The current quarterly long term liabilities of AMRX is $2.36B
What is the all time high quarterly long term liabilities for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly total long term liabilities is $3.02B
What is Amneal Pharmaceuticals, Inc. quarterly long term liabilities year-on-year change?
Over the past year, AMRX quarterly total long term liabilities has changed by -$37.25M (-1.55%)